| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $738,945 | 2 | 50 |
Sells | $2,575,601 | 2 | 50 |
| LONDON SARAH | Chief Executive Officer | 1 | $490,365 | 0 | $0 | $490,365 |
| Samuels Theodore R. II | director | 1 | $248,580 | 0 | $0 | $248,580 |
| Burdick Kenneth A | director | 0 | $0 | 2 | $2.58M | $-2.58M |
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Over the last 12 months, insiders at Centene Corporation have bought $738,945 and sold $2.58M worth of Centene Corporation stock.
On average, over the past 5 years, insiders at Centene Corporation have bought $1.83M and sold $10.3M worth of stock each year.
Highest buying activity among insiders over the last 12 months: LONDON SARAH (Chief Executive Officer) — $490,365. Samuels Theodore R. II (director) — $248,580.
The last purchase of 19,230 shares for transaction amount of $490,365 was made by LONDON SARAH (Chief Executive Officer) on 2025‑08‑08.
| 2025-12-04 | Sale | Burdick Kenneth A | director | 32,796 0.0067% | $39.00 | $1.28M | +5.92% | |
| 2025-12-03 | Sale | Burdick Kenneth A | director | 33,211 0.0068% | $39.04 | $1.3M | +5.64% | |
| 2025-08-08 | LONDON SARAH | Chief Executive Officer | 19,230 0.0039% | $25.50 | $490,365 | +44.31% | ||
| 2025-07-28 | Samuels Theodore R. II | director | 9,000 0.0019% | $27.62 | $248,580 | +35.70% | ||
| 2024-12-18 | Greco Thomas | director | 17,000 0.0034% | $59.75 | $1.02M | -8.66% | ||
| 2024-12-16 | COUGHLIN CHRISTOPHER J | director | 10,000 0.002% | $59.44 | $594,400 | -7.45% | ||
| 2024-12-16 | Dallas H James | director | 1,693 0.0003% | $59.01 | $99,904 | -7.45% | ||
| 2024-12-16 | BLUME JESSICA L. | director | 250 <0.0001% | $59.48 | $14,870 | -7.45% | ||
| 2024-12-13 | Samuels Theodore R. II | director | 5,000 0.001% | $58.86 | $294,300 | -7.59% | ||
| 2024-11-13 | Asher Andrew Lynn | Chief Financial Officer | 17,200 0.0034% | $58.14 | $1M | -2.08% | ||
| 2024-11-08 | LONDON SARAH | Chief Executive Officer | 4,117 0.0008% | $60.80 | $250,314 | -4.59% | ||
| 2024-05-14 | Sale | COUGHLIN CHRISTOPHER J | director | 878 0.0002% | $76.75 | $67,382 | -17.67% | |
| 2024-05-13 | Sale | FASOLA KENNETH J | President | 8,000 0.0015% | $77.62 | $620,960 | -17.74% | |
| 2024-02-13 | Sale | Robinson Lori Jean | director | 10,000 0.0019% | $77.41 | $774,100 | -7.26% | |
| 2024-02-07 | Sale | FASOLA KENNETH J | President | 12,000 0.0023% | $75.07 | $900,818 | -4.40% | |
| 2023-04-27 | Sale | Robinson Lori Jean | director | 1,400 0.0002% | $66.59 | $93,226 | +3.45% | |
| 2023-03-17 | LONDON SARAH | Chief Executive Officer | 30,000 0.0055% | $62.60 | $1.88M | +10.24% | ||
| 2023-02-10 | Asher Andrew Lynn | EVP, CFO | 3,800 0.0007% | $71.97 | $273,486 | -5.84% | ||
| 2023-02-09 | Asher Andrew Lynn | EVP, CFO | 3,000 0.0005% | $71.89 | $215,670 | -4.28% | ||
| 2023-02-08 | MURRAY JAMES E | EVP, Chief Operating Officer | 6,750 0.0012% | $73.30 | $494,775 | -6.06% |
| LONDON SARAH | Chief Executive Officer | 845275 0.172% | $34.86M | 3 | 0 | +2.83% |
| Burdick Kenneth A | director | 272365 0.0554% | $11.23M | 0 | 12 | |
| Samuels Theodore R. II | director | 32000 0.0065% | $1.32M | 4 | 0 | <0.0001% |
| NEIDORFF MICHAEL F | Chairman & CEO | 6404073 1.3029% | $264.1M | 1 | 43 | <0.0001% |
| LAYTON BRENT D | President & COO | 530204 0.1079% | $21.87M | 0 | 4 | |
| Asher Andrew Lynn | Chief Financial Officer | 486847 0.099% | $20.08M | 3 | 0 | <0.0001% |
| Schwaneke Jeffrey A. | EVP, HealthCare Enterprises | 454549 0.0925% | $18.75M | 0 | 13 | |
| Hunter Jesse N | EVP, M&A & Chief Strategy Ofcr | 411792 0.0838% | $16.98M | 0 | 25 | |
| BURKHALTER BRANDY | EVP, Chief Operating Officer | 379399 0.0772% | $15.65M | 0 | 4 | |
| JOHNSON CLAIRE W | director | 339584 0.0691% | $14M | 0 | 2 | |
| FASOLA KENNETH J | President | 300357 0.0611% | $12.39M | 0 | 2 | |
| ROBERTS JOHN R | director | 194465 0.0396% | $8.02M | 2 | 4 | +15.73% |
| SCHEFFEL WILLIAM N | Exec VP, CFO & Treasurer | 186987 0.038% | $7.71M | 1 | 6 | +33.45% |
| Williamson Keith H | EVP, Secr. & General Counsel | 176376 0.0359% | $7.27M | 0 | 22 | |
| Imholz Donald G | EVP, Operations and CIO | 170822 0.0348% | $7.04M | 0 | 10 | |
| Thompson Tommy G | director | 160896 0.0327% | $6.64M | 3 | 8 | +21.41% |
| BROOKS MARK J | EVP, Chief Information Officer | 153755 0.0313% | $6.34M | 0 | 10 | |
| EPPINGER FREDERICK H | director | 145602 0.0296% | $6M | 0 | 1 | |
| MURRAY JAMES E | EVP, Chief Operating Officer | 136220 0.0277% | $5.62M | 1 | 0 | <0.0001% |
| BOWERS CHRISTOPHER D | EVP, Markets | 121898 0.0248% | $5.03M | 0 | 6 | |
| KOSTER CHRISTOPHER | SVP, Secr. & General Counsel | 120754 0.0246% | $4.98M | 0 | 1 | |
| BAGLEY SHANNON | EVP, Chief Admin. Officer | 118194 0.024% | $4.87M | 0 | 2 | |
| Baldwin Kenneth Rone | EVP, Markets | 111494 0.0227% | $4.6M | 0 | 4 | |
| WIEDERHOLD RICHARD P | director | 101834 0.0207% | $4.2M | 0 | 10 | |
| THOMAS DAVID P | EVP, MARKETS | 82253 0.0167% | $3.39M | 0 | 1 | |
| AYALA ORLANDO | director | 74879 0.0152% | $3.09M | 1 | 9 | +31.65% |
| WITTY KAREY L | SVP, Health Plan Business Unit | 57500 0.0117% | $2.37M | 0 | 13 | |
| DITMORE ROBERT K | director | 56330 0.0115% | $2.32M | 3 | 26 | +4.74% |
| TONEY COLIN A | EVP, Mergers & Acquisitions | 55101 0.0112% | $2.27M | 0 | 1 | |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 45048 0.0092% | $1.86M | 0 | 5 | |
| KROLL EDMUND E | SVP Fin & Investor Relations | 41780 0.0085% | $1.72M | 0 | 2 | |
| COUGHLIN CHRISTOPHER J | director | 36358 0.0074% | $1.5M | 2 | 1 | <0.0001% |
| DROZDA JOSEPH P JR | Sr. VP & Chief Medical Officer | 32181 0.0065% | $1.33M | 0 | 11 | |
| CASSO KATIE | SVP & Corporate Controller | 31977 0.0065% | $1.32M | 0 | 1 | |
| GOLDMAN CAROL | Exec VP Chief Admin Officer | 30801 0.0063% | $1.27M | 0 | 24 | |
| BARTLETT STEVE | director | 29554 0.006% | $1.22M | 5 | 0 | +16.18% |
| GEPHARDT Richard A | 22560 0.0046% | $930,392.13 | 0 | 13 | ||
| HOBBS CARY | SVP, Bus Mgmt & Integration | 20768 0.0042% | $856,472.32 | 0 | 10 | |
| SPANEL BRIAN G | Sr Vice President, Development | 19999 0.0041% | $824,758.76 | 0 | 1 | |
| Greco Thomas | director | 19309 0.0039% | $796,303.16 | 1 | 0 | <0.0001% |
| JOSEPH PAMELA A | director | 17398 0.0035% | $717,509.89 | 1 | 0 | +5.94% |
| BRADT SAMUEL E | director | 13960 0.0028% | $575,710.40 | 0 | 12 | |
| Robinson Lori Jean | director | 11455 0.0023% | $472,404.20 | 0 | 3 | |
| STEWARD DAVID L | director | 9500 0.0019% | $391,780.00 | 1 | 0 | +16.99% |
| Mason Mary V | SVP & Chief Medical Officer | 4344 0.0009% | $179,141.90 | 0 | 2 | |
| Dallas H James | director | 1693 0.0003% | $69,819.32 | 2 | 0 | <0.0001% |
| BLUME JESSICA L. | director | 250 0.0001% | $10,310.00 | 2 | 0 | +2.6% |
| CAHILL EDWARD L | director | 0 0% | $0 | 0 | 2 | |
| HALVERSON CATHERINE M | Senior VP Business Development | 0 0% | $0 | 0 | 1 | |
| PAQUIN DAN | Sr. VP New Plan Implementation | 0 0% | $0 | 0 | 2 | |
| TADICH JOHN | Senior VP, Specialty Companies | 0 0% | $0 | 0 | 2 |
| Increased Positions | 558 | +65.42% | 92M | +19.14% |
| Decreased Positions | 379 | -44.43% | 95M | -19.87% |
| New Positions | 197 | New | 17M | New |
| Sold Out Positions | 99 | Sold Out | 7M | Sold Out |
| Total Postitions | 1,032 | +20.98% | 476M | -0.73% |
| Vanguard Group Inc | $2.37M | 11.54% | 56.79M | -2M | -2.75% | 2025-09-30 |
| Blackrock, Inc. | $1.89M | 9.22% | 45.35M | +137,569 | +0.3% | 2025-09-30 |
| Norges Bank | $1.11M | 5.38% | 26.46M | +1M | +4.33% | 2025-06-30 |
| State Street Corp | $893,988.00 | 4.35% | 21.4M | -2M | -7.72% | 2025-09-30 |
| Aqr Capital Management Llc | $612,279.00 | 2.98% | 14.65M | +6M | +76.59% | 2025-09-30 |
| Geode Capital Management, Llc | $525,351.00 | 2.56% | 12.57M | -634,424 | -4.8% | 2025-09-30 |
| D. E. Shaw & Co., Inc. | $444,081.00 | 2.16% | 10.63M | +8M | +270.16% | 2025-09-30 |
| Invesco Ltd. | $443,088.00 | 2.16% | 10.61M | -1M | -9.56% | 2025-09-30 |
| Harris Associates L P | $381,366.00 | 1.86% | 9.13M | -11M | -55.3% | 2025-09-30 |
| Deerfield Management Company, L.P. | $377,942.00 | 1.84% | 9.05M | +6M | +183.99% | 2025-09-30 |